Compare Canada's negotiated generic drug system with the USA's market-driven approach. Discover why prices differ, how shortages are handled, and what this means for patient access and costs.
Details
Explore why generic drug prices are often lower in the US than in Europe, despite higher overall healthcare costs, and how market structures drive this paradox.
Details